| Regulating Pair |
| Introduced Variation |
Knockout of NAT1 |
Protein Info
|
| Induced Change |
Palmitoleoylethanolamde concentration: increase (FC = 3) |
Metabo Info
|
| Summary |
Introduced Variation
Induced Change
|
|
|
|
|
|
|
|
| Full List of Experiment(s) Validating This Regulating Pair |
| Details of Experiment for Validating This Pair |
[1] |
| Method |
Quantifying the change of palmitoleoylethanolamde concentration after NAT1 knockout through ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) based metabolomics. |
| Disease Status |
Breast cancer |
ICD-11: 2C60 |
| Organ/Tissue/Cell Line |
MDA-MB-231 cells (Human breast cancer cells) |
Breast |
| Subcellular Location |
Cytoplasm |
| Tested Species |
Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
|
| Details |
It is reported that knockout of NAT1 leads to the increase of palmitoleoylethanolamde levels compared with control group in MDA-MB-231 cells. |
|
|
|
|
|
|
|
| References |
| 1 |
CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism. Sci Rep. 2020 Jun 17;10(1):9804.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.
